International Journal of Pharma and Bio Sciences
 
 
    ISSN 0975-6299
www.ijpbs.net


ORIGINAL RESEARCH ARTICLE
Int J Pharm Bio Sci Volume 13 Issue 1, January - March, Pages:29-36

Arginine as A Potential Therapy against Ischemic/Reperfusion Injury in Rat Model

Dr. Debopriya Ghosh, Dr. Sandeep Mukharjee and Rajasekaran Rajkumar
DOI: http://dx.doi.org/10.22376/ijpbs.2022.13.1.B29-36
Abstract:

: Adnexal torsion (Ovarian torsion) is a rare gynaecologic emergency with a prevalence of 2.7%. This denotes the bending of the ovary and fallopian tube around the broad ligament. Early diagnosis and treatment is necessary for the preservation of the affected ovary. Hence, fertility as long-term arterial, venous or lymphatic obstruction of the ovary causes a critical reduction in tissue blood flow and permanent tissue damage. The aim of ischemia treatment is not only to achieve blood flow but also to restore tissue reperfusion. In this study eight weeks old 15 female Adult albino rats (Wister strain) of body weight 130-150 gm gm were used for this experiment . Experimental animals were divided into 3 groups according to their treatment, bull dog clip induced artificial ischemia was induced followed by respective periods of reperfussive time. Treatment with L arginine was performed with dedicated experimental animal group. This study shows that ischemia/reperfusion causes oxidative stress and alteration in ovarian tissue architecture as revealed by increased oedema, vascular congestion clots and tissue degeneration in a rat model of ovarian torsion and the intervention/ therapeutic use of  L-arginine could be applied as a therapeutic agents to treat  shows that the ischemic/reperfusion mediate alterations in ovarian tissue. The study showed   that the decreased oxidative stress parameters and reversal of changes in ovarian architecture after treating with L-Arginine.. Moreover it can be said that the potential effect of L-arginine can be used to reduced I/R injury in rat ovary along with overian torson induced changes in animal models, although more specific and broad study required to use the therapeutic value of L arginine on a clinical setup. 

 

Keywords: L-arginine, nitric oxide synthase, oxidative stress, ischemia/reperfusion injury.
Full HTML:

REFERENCES 

  1. Am AJR J. Roentgenol. Doppler Sonogr. 1992;159(6):1251-3.
  2. Rabêlo LA, Souza VN, Fonseca LJ, Sampaio WO. Redox unbalance: NADPH oxidase as therapeutic target in blood pressure control. Arq Bras Cardiol. 2010;94(5):643-51, 684, 684-93. doi: 10.1590/s0066-782x2010000500018, PMID 20549031.
  3. Schmidt HH, Nau H, Wittfoht W, Gerlach J, Prescher KE, Klein MM, Niroomand F, Böhme E. Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol. 1988;154(2):213-6. doi: 10.1016/0014-2999(88)90101-x, PMID 3265919.
  4. Simmons SO, Fan CY, Ramabhadran R. Cellular stress response pathway system as a sentinel ensemble in toxicological screening. Toxicol Sci. 2009;111(2):202-25. doi: 10.1093/toxsci/kfp140, PMID 19567883.
  5. Tsao PS, Lefer AM. Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. Am J Physiol. 1990;259(6 Pt 2):H1660-6. doi: 10.1152/ajpheart.1990.259.6.H1660, PMID 2260693.
  6. White M, Stella J. Ovarian torsion: 10-year perspective. Emerg Med Australas. 2005 Oct;17(3):231-7. doi: 10.1111/j.1742-6723.2005.00728.x, PMID 15953224.
  7. Xiao D, Bird IM, Magness RR, Longo LD, Zhang L. Up regulation of eNOS in pregnant ovine uterine arteries by chronic hypoxia. Am J Physiol Heart Circ Physiol. 2001;280(2):H812-20. doi: 10.1152/ajpheart.2001.280.2.H812, PMID 11158981.
  8. Xu W, Kaneko FT, Zheng S, Comhair SA, Janocha AJ, Goggans T, Thunnissen FB, Farver C, Hazen SL, Jennings C, Dweik RA, Arroliga AC, Erzurum SC. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J. 2004;18(14):1746-8. doi: 10.1096/fj.04-2317fje, PMID 15364894.
  9. Yoshida S, Abe K, Busto R, Watson BD, Kogure K, Ginsberg MD. Influence of transient ischemia on lipid-soluble antioxidants, free fatty acids and energy metabolites in rat brain. Brain Res. 1982;245(2):307-16. doi: 10.1016/0006-8993(82)90813-7, PMID 7127075
  10. Zackrisson U, Mikuni M, Wallin A, Delbro D, Hedin L, Brännström M. Cell-specific localization of nitric oxide synthases (NOS) in the rat ovary during follicular development, ovulation and luteal formation. Hum Reprod. 1996;11(12):2667-73. doi: 10.1093/oxfordjournals.humrep.a019189, PMID 9021370.
  11. Zembowicz A, Hecker M, Macarthur H, Sessa WC, Vane JR. Nitric oxide and another potent vasodilator are formed from NG-hydroxy-L-arginine by cultured endothelial cells. Proc Natl Acad Sci U S A. 1991;88(24):11172-6. doi: 10.1073/pnas.88.24.11172, PMID 1662386.
  12. Zhang C, Hein TW, Wang W, Miller MW, Fossum TW, McDonald MM, Humphrey JD, Kuo L. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension. 2004;44(6):935-43. doi: 10.1161/01.HYP.0000146907.82869.f2, PMID 15492130.
  13. Ridnour LA, Thomas DD, Donzelli S, Espey MG, Roberts DD, Wink DA, Isenberg JS. The biphasic nature of nitric oxide responses in tumor biology. Antioxid Redox Signal. 2006;8(7-8):1329-37. doi: 10.1089/ars.2006.8.1329, PMID 16910780.
  14. Naffaa L, Deshmukh T, Tumu S, Johnson C, Boyd KP, Meyers AB. Imaging of acute pelvic pain in girls: ovarian torsion and beyond?. Curr Probl Diagn Radiol. 2017;46(4):317-29. doi: 10.1067/j.cpradiol.2016.12.010, PMID 28185689.
  15. Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro LJ. Nitric oxide and atherosclerosis: an update. Nitric Oxide. 2006;15(4):265-79. doi: 10.1016/j.niox.2006.03.011, PMID 16684613.
  16. Phillips L, Toledo AH, Lopez-Neblina F, Anaya-Prado R, Toledo-Pereyra LH. Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg. 2009;22(1):46-55. doi: 10.1080/08941930802709470, PMID 19191157.
  17. Preston TJ, Muller WJ, Singh G. Scavenging of extracellular H2O2 by catalase inhibits the proliferation of HER-2/Neu-transformed rat-1 fibroblasts through the induction of a stress response. J Biol Chem. 2001;276(12):9558-64. doi: 10.1074/jbc.M004617200, PMID 11134000.
  18. Elsarrag SZ, Forss AR, Richman S, Salih SM. Acute ovarian insufficiency and uterine infarction following uterine artery embolization for postpartum hemorrhage. Clinical medical reviews and case reports. 2015 Jun;2(2).
  19. Nikolaou D, Templeton A. Early ovarian ageing: a hypothesis: detection and clinical relevance. Human Reproduction. 2003 Jun 1;18(6):1137-9.
  20. Higa T, Shiraishi M, Mamadi T, Taira K, Oshiro T, Nozato E, Nagahama M, Muto Y. Limitations of exogenous L-arginine in exerting a cytoprotective effect on hepatic ischemia/reperfusion injury. Surgery today. 2000 Mar;30(4):352-9.

 

 

 

[Download PDF]
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© Copyright 2009-2015 IJPBS, India. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech Solutions
         Home I Contact I Terms & Conditions